Loading Kwality Pharmaceuticals…
| ₹ Cr | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 162 | 157 | 123 | 111 | 111 |
| Operating profit | 36 | 33 | 25 | 20 | 19 |
| Operating margin | 22.2% | 21.3% | 20.4% | 18.4% | 17.4% |
| Net profit | 26 | 25 | 16 | 14 | 12 |
| Net margin | 15.8% | 16.1% | 13.0% | 12.7% | 10.7% |
| EPS (₹) | 24.69 | 24.39 | 15.42 | 13.60 | 11.49 |
Quarters are labelled by period end.
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 503 | 370 | 307 | 251 |
| Operating profit | 98 | 62 | 47 | 46 |
| Operating margin | 19.6% | 16.8% | 15.2% | 18.2% |
| Net profit | 67 | 40 | 24 | 19 |
| Net margin | 13.4% | 10.8% | 7.7% | 7.7% |
| EPS (₹) | 64.90 | 38.40 | 22.93 | 18.67 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 592 | 447 | 394 | 354 |
| Total liabilities | 262 | 185 | 172 | 155 |
| Shareholders’ equity | 332 | 264 | 224 | 201 |
| Total debt | 131 | 112 | 98 | 90 |
| Cash & equivalents | 1 | 12 | 2 | 3 |
| Debt / equity | 0.39 | 0.43 | 0.44 | 0.45 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 17 | 53 | 43 | 41 |
| Capital expenditure | -49 | -25 | -30 | -48 |
| Free cash flow | -32 | 28 | 13 | -6 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 20.3% | 15.1% | 10.6% | 9.7% |
| Return on assets | 11.4% | 8.9% | 6.0% | 5.5% |
| Net margin | 13.4% | 10.8% | 7.7% | 7.7% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for KPL. Finnhub coverage is limited for some India-listed stocks.